Published in
American Association for the Advancement of Science, Science Advances, 13(6), 2020
Links
Tools
In vivo priming of human mesenchymal stem cells with hepatocyte growth factor–engineered mesenchymal stem cells promotes therapeutic potential for cardiac repair
Journal article published in 2020 by
Bong-Woo Park 
,
Soo-Hyun Jung,
Sanskrita Das ,
Soon Min Lee ,
Jae-Hyun Park,
Hyeok Kim ,
Ji-Won Hwang ,
Sunghun Lee ,
Hyo-Jin Kim ,
Hey-Yon Kim ,
Seungman Jung,
Dong-Woo Cho,
Jinah Jang ,
Kiwon Ban ,
Hun-Jun Park
,
Soo-Hyun Jung,
Sanskrita Das ,
Soon Min Lee ,
Jae-Hyun Park,
Hyeok Kim ,
Ji-Won Hwang ,
Sunghun Lee ,
Hyo-Jin Kim ,
Hey-Yon Kim ,
Seungman Jung,
Dong-Woo Cho,
Jinah Jang ,
Kiwon Ban ,
Hun-Jun Park
This paper is made freely available by the publisher.
Full text: Download
Postprint:
archiving forbidden
Data provided by 
Abstract
Priming human BM-MSCs with engineered HGF-MSCs in vivo significantly improves therapeutic potential for myocardial infarction.